End-stage kidney disease and COVID-19: An incentive to consider other renal replacement therapies
No Abstract No Abstract No Abstract No Abstract
Main Authors: | Sima Sadat Hejazi, Meimanat Hosseini, Abbas Ebadi, Hamid Alavi Majd |
---|---|
Format: | Article |
Language: | English |
Published: |
Tehran University of Medical Sciences
2021-02-01
|
Series: | Nursing Practice Today |
Subjects: | |
Online Access: | https://npt.tums.ac.ir/index.php/npt/article/view/1363 |
Similar Items
-
End-Stage Kidney Disease From Scleroderma in the United States, 1996 to 2012
by: Donal J. Sexton, et al.
Published: (2018-01-01) -
End-stage kidney disease and rationing of kidney replacement therapy in the free state province, South Africa: a retrospective study
by: Thabang T Molaoa, et al.
Published: (2021-05-01) -
Comparison of High-Flux and Low-Flux Hemodialysis Filters on Hemodialysis Adequacy in Under-Hemodialysis Patients with End-Stage Renal Disease
by: Rouhollah Narimani, et al.
Published: (2015-06-01) -
Rising Incidence of End-Stage Kidney Disease and Poorer Access to Kidney Transplant Among Australian Aboriginal and Torres Strait Islander Children and Young Adults
by: Swasti Chaturvedi, et al.
Published: (2021-06-01) -
Renal replacement therapy in Korea, 2012
by: Dong Chan Jin, et al.
Published: (2014-03-01)